Montgomery Community Media

Rep. David Trone (MD-06) toured Novavax, a biotechnology company in Gaithersburg this morning to learn more about the company’s vaccine trials and planned expansion. The Novavax COVID-19 vaccine is currently in phase 3 of clinical trials, showing an efficacy rating of nearly 90%. The company plans to seek FDA approval soon. During his visit, Trone […]

The Gaithersburg biotechnology company, Novavax, announced Monday morning data from phase 3 of its COVID-19 vaccine trials which were conducted in the United States and Mexico. Novavax found that the trial, which began in December and enrolled 29,960 participants, had an overall efficacy rate of 90.04%. Last year, Novavax was awarded $1.6 billion from the […]

El gobernador Larry Hogan y otros líderes visitaron Gaithersburg el jueves para recorrer el sitio de la futura sede mundial de Novavax. Hace más de un año, Novavax comenzó a desarrollar una vacuna COVID-19. Stan Erck, presidente y director ejecutivo de Novavax, dijo que Novavax está completando la fase tres de los ensayos de vacunas […]

Gov. Larry Hogan and other leaders visited Gaithersburg on Thursday to tour the site of Novavax’s future global headquarters. More than a year ago, Novavax began developing a promising COVID-19 vaccine. Stan Erck, the president and CEO of Novavax, said that Novavax is completing phase three of vaccine trials and results have been promising. “I’m happy to […]

A Massachusetts-based biotechnology company announced Monday that it will open a facility in Rockville in the coming years. TCR² Therapeutics Inc., based in Cambridge, is a clinical-stage company that develops T-cell therapies for patients with cancer. In a statement, TCR² said it signed a long-term, full-building lease for an existing 85,000 sq. ft. facility. The […]

Vigene Biosciences, a Maryland-based biotechnological company whose projects include a potential COVID-19 nasal spray vaccine, is looking to expand in Montgomery County with a new facility in Rockville. The new facility, which will be located at 14200 Shady Grove Road, will encompass 52,000 square feet of manufacturing space for its 125 current employees and hopes […]

Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine.  In a statement the company said the vaccine is in multiple Phase 2 clinical trials right now. Novavax expects to finalize an agreement that would begin supplying the doses […]

Two Maryland companies are partnering to manufacture  a potential vaccine candidate for COVID-19. Gaithersburg-based Altimmune, a clinical stage biopharmaceutical company and Vigene Biosciences, a Rockville-based biotechnology company, announced the partnership in a press release July 22. The vaccine, known as AdCOVID (TM), works to block infection by stimulating antibodies in the nasal cavity and can […]

Altimmune, Inc, a clinical-stage immunotherapeutics biotechnology company, announced on Tuesday that it will relocate new employees acquired as a result of its merger with Pharmathene, and existing employees, to a new 14,000 square-foot location in Gaithersburg. The new facility, located at 910 Clopper Road, is planned to be complete by the beginning of 2018 and […]

The 2016 Regional BioTech Forum was held this week at MedImmune in Gaithersburg, and the talk of the two-day meeting was the importance of growing the sector. MyMCMedia’s Sonya Burke reports. Pleased to meet Leaders of Tomorrow at #biotechforum16 #NIH pic.twitter.com/JOjQZ1GIOu — Francis S. Collins (@NIHDirector) April 19, 2016 Dr. Collins @NIHDirector @NIH, on exceptional […]